Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

Cisplatin 2fluoroazomycin arabinoside 1fludarabine phosphate 1fludarabine 1aldesleukin 1Radiotherapy, Intensity-Modulated 1Panitumumab 1Paclitaxel 1Nivolumab 1Metformin 1Interleukin-2 1Fluorouracil 1Docetaxel 1Cyclophosphamide 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Adenosquamous × Radiotherapy, Intensity-Modulated × Clear all
NCT00513383 2017-03-01

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Massachusetts General Hospital

Phase 1 Completed
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡